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The ACTA PORT-Score for predicting the Perioperative Risk of blood Transfusion for adult 
patients undergoing cardiac surgery 
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ABSTRACT 
 
Objective: To derive a simple and accurate scoring system to predict risk of transfusion for 
patients undergoing cardiac surgery 
Design: Retrospective analysis of data collected from the ACTA National Audit; for the 
derivation dataset, we included data from 20,036 patients, which we then externally validated 
using a further group of 1,047 patients. 
Methods: We identified independent risk factors associated with transfusion by performing 
univariate analysis, followed by logistic regression. We then simplified the score to an 
integer-based system and tested it using AUC characteristic statistic. A Hosmer-Lemeshow 
goodness-of-fit test was applied. Finally, the scoring system was applied to the external 
validation dataset and the same statistical methods applied to test the accuracy of the ACTA-
PORT score. 
Results: Several factors were shown to be independently associated with risk of transfusion. 
These included age, gender, body surface area, logistic EuroSCORE, preoperative 
haemoglobin and creatinine, and type of surgery. In our primary dataset, the score accurately 
predicted risk of perioperative transfusion in cardiac patients with an AUC of 0.76. The 
external validation confirmed the accuracy of the scoring method with an AUC of 0.84 and 
good agreement across all scores with a minor tendency to under-estimate transfusion risk in 
very high-risk patients.  
Conclusion: The ACTA-PORT score is a reliable, validated tool for predicting the risk of 
transfusion for patients undergoing cardiac surgery. This score will allow clinicians to easily 
identify patients at increased risk for transfusion and apply patient blood management 
strategies appropriately, with the potential to reduce perioperative morbidity and mortality. 
Keywords: transfusion; anaesthesia, cardiovascular; risk prediction 
 
INTRODUCTION 
 
Cardiac surgery has long been associated with comparatively high rates of blood product 
transfusion. Blood products are a limited resource and are both expensive and resource-
intensive; cardiac surgery consumes a significant proportion of these global blood resources. 
There is conflicting evidence supporting the relative merits of restrictive1 or liberal2 
transfusion triggers, but there is a significant body of evidence that any perioperative 
transfusion is associated with higher risk of mortality in both the short-3 and long-term.4 
Several factors have been shown to be independently associated with transfusion in 
cardiac surgery patients. These include age,5 gender, pre-operative haemoglobin 
concentration (Hb), elevated plasma creatinine3 and low body weight.3 Various attempts have 
been made to synthesise these predisposing factors into a predictive scoring system,6-8 but as 
yet none have become widely established.   
Patient blood management (PBM) is an increasingly important concept in 
perioperative medicine and as with any risk-reduction strategy, the first step is to predict 
individual risk, followed by targeted strategies to mitigate this risk.9 This allows for 
appropriate and focussed use of PBM strategies, which may include medication and 
techniques that can be expensive, or may result in harmful side-effects, and should be 
therefore be reserved for those at higher risk of transfusion. Scoring systems to predict 
general mortality and morbidity are widely used in cardiac surgery and critical care, such as 
the EuroSCORE10 and the recently published ARCTIC score11. A similar scoring system to 
guide effective perioperative PBM could have a major impact on resource allocation and 
potentially on perioperative morbidity. We therefore decided to design the Association of 
Cardiothoracic Anaesthetists (ACTA) perioperative risk of blood transfusion score – the 
ACTA-PORT score, using a large national database collected by members of ACTA. 
 
METHODS 
 
This study comprises a national service audit of NHS cardiac surgery centres that collected 
relevant patient data as part of routine institutional practice. The Research and Ethics 
Committee of the London School of Hygiene and Tropical Medicine approved the study, and 
individual patient consent was not required. Between 1st January 2010 and 31st July 2013, 
data were collected from 10 cardiac surgery centres in the UK during the first ACTA national 
audit; an analysis of the effect of anaemia has already been published.11 After the analysis 
was complete, a further centre provided data from the same study period – this was analysed 
as the external validation dataset. 
Baseline data collected included age, gender, pre-operative haemoglobin (Hb) creatinine, 
weight, height, logistic EuroSCORE, diabetes, hypertension, type of surgery proposed and 
previous cardiac surgery. Body mass index (BMI) and body surface area (BSA) were derived 
from weight and height. These variables were chosen because we a priori expected them to be 
associated with outcome. Outcomes recorded included number of units of blood transfused, 
duration of ICU and hospital stay, and death.  
As our goal was to produce a simple-to-use integer risk score, the continuous variables age, 
preoperative haemoglobin, creatinine, logistic EuroSCORE, BMI and BSA were all 
categorised using clinical judgement where available or otherwise following graphical 
inspections and taking into account the distribution of the outcome. We used logistic 
EuroSCORE as EuroSCORE-2 was not in routine use in the NHS during the study period. 
Although EuroSCORE was designed to calculate the risk of mortality (as opposed to 
transfusion), we included it as a separate variable to aid in the calculation of risk of 
transfusion. Operation type was grouped into three categories; isolated CABG or valve 
surgery, combination surgeries (CABG and valve, or valve and valve), and other (including 
operations on the aorta). 
The univariate association between each of the baseline variables and the outcome of blood 
transfusion was assessed using logistic regression. Forward and backward stepwise model 
building approaches were used in developing a final multivariable logistic regression model 
using a threshold for inclusion or exclusion of P < 0.05. Both approaches yielded identical 
final models. A restricted set of pre-specified potential interactions were investigated using 
likelihood ratio tests.  
As our goal was to produce a risk score that is generalisable beyond the centres involved in 
this audit, centre was not included as a fixed effect in the model. We compared multivariable 
logistic regression models omitting centre completely and multivariable mixed effects logistic 
regression models including centre as a random effect. These two approaches produced 
almost identical results in terms of the estimate odds ratios and the overall model 
performance and we therefore decided to proceed with the former.  
Adjusted odds ratios and 95% confidence intervals for the final multivariable model are 
presented along with p-values from a likelihood ratio test. For each variable in the model, we 
set the lowest risk category as the reference group so that the risk score would only involve 
the addition of points. The logistic odds ratio for each category was converted into an integer 
by dividing by 0.2 and rounding to nearest the nearest whole number. The total integer risk 
score for each patient was then calculated by summing the points associated with their 
combination of baseline risk factors.  
The discriminatory performance of the risk score before and after simplification was assessed 
using the area under the receiver operating characteristic curve (AUC) statistic. The goodness 
of fit of the models i.e. how closely predicted risk matched observed risk, was assessed using 
the Hosmer-Lemeshow goodness-of-fit test.  
The predicted risk of transfusion associated with each value of the total integer risk score was 
calculated and presented in a table and figure. We grouped the risk score into six equally 
spaced categories (0-4, 5-9, 10-14, 15-19, 20-24 and 25-30) and plotted the observed versus 
predicted proportion of patients transfused in each category.  
We assessed the sensitivity of our results to the influence of missing data using multiple 
imputation. Multiple imputation with chained equations was used to generate 20 completed 
datasets. The selected model was then fitted to each of the 20 completed datasets and the 
estimated coefficients were combined according to Rubin’s rules. 
An external validation of the integer risk score was carried out using data from a further 
cardiac surgical centre. The integer risk score was calculated for each patient in the external 
dataset and the performance of the risk score was assessed using the AUC and the Hosmer-
Lemeshow goodness-of-fit test. We grouped the risk score for the validation patients into the 
same categories as described above for the derivation data and plotted the observed versus 
predicted risk of transfusion. We also used our validation dataset to compute the TRACK 
score and compared our model with TRACK using the DeLong method. We were unable to 
calculate any other published risk scores as we did not collect the required variables. 
The analysis was carried out using Stata 14 (StataCorp, College Station, TX).  
Patient involvement. 
Patients/service users/lay people were not involved in the design of this study.  
RESULTS 
 
We analysed data from 20,036 patients, whose baseline characteristics are shown in Table 1. 
A total of 8,635 (43%) patients were transfused. 
Table 1 shows the baseline characteristics of the patients overall and by the outcome of blood 
transfusion. The mean age of the patients in this audit was 67 years [range 18, 111] and 71% 
were male. Mean pre-operative haemoglobin was 132 g/L with 31% of patients being 
anaemic (< 130/< 120 g/L for males/females respectively). Haemoglobin was not available 
for 16% of patients in this audit. Of the 20,036 patients 8,635 (43%) received a blood 
transfusion perioperatively.  
With the exception of a known history of hypertension, all the baseline variables were 
strongly associated with the risk of blood transfusion (all P < 0.001) in the univariate 
analysis. Age, EuroSCORE, female gender, diabetes and elevated creatinine were positively 
associated with the risk of transfusion. Haemoglobin, BMI and BSA were negatively 
associated with the risk of transfusion. Patients undergoing combination surgery were more 
likely to be transfused. There were marked differences in transfusion rates among the 10 
centres, which ranged from 31% to 56% (Table 2). 
Table 3 shows the adjusted odds ratios, 95% CIs and p-values for the 7 variables included in 
the final multivariable risk score. During the model building process, it was found that BSA 
was a stronger predictor of transfusion than BMI. Neither history of hypertension nor 
diabetes were found to be independently associated with risk of transfusion. Table 2 also 
shows the log-odds ratio, their standard errors and the integer points associated with each 
category. Other than age (p = 0.02), all the variables in the multivariable risk score were 
strongly associated with the outcome (p < 0.001). No statistically significant interactions 
were found. The strongest predictor of transfusion was baseline Hb, followed by BSA and 
EuroSCORE. The AUC for the integer risk score model was 0.760 (95% CI 0.752, 0.768) and 
the Hosmer-Lemeshow goodness-of-fit test provided no evidence of a poor fit (p=0.23). The 
AUC from the non-integer risk model (i.e. using the log-odds ratios) was 0.762 indicating 
that little predictive power had been lost through the simplification process. 
The risk score for any patient is simply calculated by adding the points associated with their 
baseline characteristics. 
For example, a 65 year old (+0 points) male (+0 points), with baseline Hb of 135 g/L (+3 
points), BSA of 2.0 (+2 points), logistic EuroScore of 1.5 (+2 points), creatinine of 1.5 (+1 
point) and undergoing CABG surgery (+2 points) would have a total risk score of 10 points. 
A 75 year old (+1 point) female (+1 point), with baseline Hb of 125 g/L (+6 points), BSA of 
1.8 (+4 points), logistic EuroScore of 2 (+3 points), creatinine of 2.5 (+3 points) and 
undergoing valve surgery (+2 points) would have a total risk score of 20 points.
Table 4 and Figure 1 show the predicted risk of transfusion associated with each value of the 
risk score. Figure 1 additionally shows the distribution of the risk score among the patients in 
the audit. The risk score can in theory take values ranging from 0 to 30 with a higher score 
being associated with a higher risk. For example, the risk of transfusion for the patient 
described above with a risk score of 10 is estimated to be 26.9% compared to an estimated 
risk of transfusion of 73.1% for patient with a risk score of 20. Figure 1 shows that the risk 
score is fairly normally distributed in this sample of patients with very few patients having a 
risk score below 5 (1.9%) or above 24 (1.8%). The median risk score was 14, for which the 
estimated risk of transfusion is 45%. 
 
 Figure 2 shows the observed versus predicted risk of transfusion across categories of the risk 
score. It can be seen that the score performs well in stratifying the risk of transfusion. Among 
patients with a score below 10, less than 20% were transfused compared with close to 80% of 
patients with a score of 20 or above.  There is good agreement between the predicted and 
observed probability of transfusion. 
The observed transfusion risk was more than 4 times higher among patients with a risk score 
of 20 or above compared to those with a score below 10. The AUC for the risk score in the 
external validation dataset is 0.835 (95% CI 0.810, 0.859). However, it can also be seen that 
the score tends to underestimate the risk of transfusion, particularly at higher levels of the 
score e.g. 73% and 89% observed versus 60% and 79% predicted in the 15 – 19 and 20 – 24 
categories respectively. 
The score was not designed to predict number of units of blood transfused. However, 
increasing ACTA-PORT score was associated with increased number of units of blood 
transfused peri-operatively: risk score 0-14, median units of blood transfused 0; score 15-19, 
median 1 unit; score 20-24, median 2 units; and score 25-30, median 3 units. 
The results from the sensitivity analysis using multiple imputation did not make substantial 
changes to the risk score. We also calculated the performance of the ACTA-PORT score at 
various integer risk score cut-points; the optimum cut-point was 15, with a positive predictive 
value of 69.5% and a negative predictive value of 70.9%, with 70.3% of values correctly 
predicted. 
 
DISCUSSION 
 
We have developed a simple, integer-based scoring system that is highly accurate at 
predicting the likelihood of transfusion and is the first scoring system of its kind to be 
externally validated, demonstrating its applicability in a real-world scenario. Furthermore, 
this scoring system demonstrates improved accuracy when compared with previous attempts 
to quantify perioperative transfusion risk 
The concept of a scoring system designed to predict the risk of bleeding or transfusion 
during cardiac surgery is not new.  One of the first efforts in this area was from Papworth 
Hospital.6 This system aimed to measure blood loss exceeding 2mL.kg-1.hr-1, requirement for 
fresh frozen plasma, platelets or cryoprecipitate, or return to theatre after arrival in the ICU. 
Whilst the negative predictive value of this score was high, only 27% of patients who the 
score placed in the highest risk category subsequently demonstrated major bleeding.  This 
low positive predictive value was confirmed by a subsequent external validation.7 
Whilst the Papworth Bleeding Risk Score sought to identify those patients at risk of 
excessive blood loss in the ICU after cardiac surgery, subsequent scoring systems have 
sought to predict the risk of transfusion.  A relatively recent example of this is the 
Transfusion Risk and Clinical Knowledge (TRACK) score, described in 2009.8 TRACK 
aimed to create a simple, easily applied system, based on five predictors of transfusion risk, 
assigning each variable a proportional risk score based on the clinical condition of the patient.  
This scoring system was subsequently validated against an external cohort, and proved to be 
superior to three earlier systems13-15 with an area under the receiver-operator curve (AUC) of 
0.70. Like the ACTA-PORT score, TRACK aimed to improve the utility of the scoring 
system for clinical practice due to its relative simplicity, whist at the same time remaining 
sensitive and specific for predicting transfusion risk  
Recently, Goudie and colleagues published their contribution to this field.16 This 
impressive dataset produced two risk prediction models: one for any red cell transfusion, and 
another predicting a requirement for massive transfusion. This is considerably more complex 
than the simpler TRACK and ACTA-PORT prediction models. When the Goudie model was 
published, it represented an advance on many existing scoring systems,10, 12, 15 with an AUC 
of 0.77 for any red blood cell transfusion.  ACTA-PORT represents an improvement on 
Goudie et al, retaining the simplicity and accessibility of TRACK combined with a greater 
predictive accuracy for red cell transfusion; our validation cohort demonstrating an AUC of 
0.84. We used our validation dataset to compute the TRACK score; the AUC of TRACK was 
0.781 (ACTA-PORT vs. TRACK p<0.001 using the DeLong method for comparing risk 
scores), therefore we conclude that the ACTA-PORT score performs significantly better than 
TRACK.  
Thus, ACTA-PORT represents the latest step in the evolution of pre-operative 
prediction of transfusion requirement.  Correctly applied, ACTA-PORT has the potential to 
enable the clinician to quantify this risk before surgery, thereby allowing modification of 
important risk factors during pre-operative optimisation. It will also help surgeons and 
anaesthetists plan which interventions to apply during the perioperative period. For example, 
cell salvage may be reserved for patients with increased risk of transfusion e.g. ACTA-PORT 
score >15. The risk of transfusion may also be helpful for planning blood supply in the 
nearest (hospital) blood bank, and for aiding decisions about reserving blood specifically, 
which can again reduce costs associated with surgery, e.g. no need to cross match blood if 
ACTA-PORT score <15. 
Blood transfusion during cardiac surgery is known to place additional physiological 
stress on the individual patient, and a further economic burden on health services. This 
recognition comes at a time when there is increasing debate regarding the appropriate target 
Hb during cardiac surgery, with some authors suggesting a liberal transfusion strategy is 
equivalent,2 if not superior17 to a restrictive strategy.  This has the potential to increase the 
demand for blood products in the cardiac surgery setting if effective Patient Blood 
Management (PBM) strategies are not introduced. The short- and long-term costs of blood 
transfusion during cardiac surgery are well documented,18 but as recent reports have 
suggested, the costs of developing a PBM program designed to offset such costs are not 
small.19  ACTA-PORT and similar scores, as part of an effective program of perioperative 
optimisation, have the ability to predict the requirement of patients for transfusion in the 
surgical setting, allowing more effective targeting of limited resources such as cell salvage, 
for example.  
Quite separate from the economic arguments for such a score, the avoidance of 
transfusion has substantial clinical benefits for the individual patient.  Transfusion has been 
shown to be associated with increased morbidity related to ischaemia,20 infection, 21-24 renal 
impairment,25 post-CABG graft occlusion26 and acute lung injury.27 With respect to longer 
term outcomes, Engoren and colleagues found that blood transfusion during cardiac surgery 
was associated with a doubling of the risk of death at 5 years.27 Yet this clinical intervention, 
with appropriate preoperative warning and preparation, can potentially be avoided.   
In our study, the only realistically modifiable risk factor associated with requirement 
for blood transfusion was Hb. Patients with an Hb <130 g/L accounted for nearly 50% of all 
transfusions, despite making up only one-third of the total cohort.  Using the risk profile of 
those patients included in the ACTA-PORT cohort, a PBM program that was able to increase 
a patient’s haemoglobin from 120 to 130 g/L would theoretically decrease their risk of 
requiring a transfusion during the perioperative period by 40%, with an implied reduction in 
perioperative morbidity and mortality. 
Similar to previous studies that have used the retrospective analysis of large databases 
to generate a risk score, our study suffers from some limitations. First, the preoperative 
management of patients presenting for cardiac surgery at the centres involved in the study 
was not standardised.  The possibility that patients at certain centres were exposed to 
different PBM strategies therefore cannot be excluded, and may potentially confound any 
subsequent analysis.  Such strategies may include differences in the cessation of anti-platelet 
therapies and the use of cell salvage, as well as the transfusion preferences of individual 
surgeons and centres. All the centres administered tranexamic acid routinely, but at different 
doses depending on institutional preference.   
Secondly, despite demonstrating overall reliability in predicting the risk of 
transfusion, the score does slightly underestimate the transfusion risk in higher risk categories 
of patients. Patients with an integer risk score of greater than 20 had a roughly 10% higher 
observed rate of transfusion relative to the predicted risk. This may reflect the nature of the 
validation cohort, being from a single centre, as opposed to the multi-centre model derivation 
dataset.  Consequently, the transfusion practices in the specific centre may not accurately 
reflect general transfusion practice.  This may be due to regional variation in anaemia 
incidence as described by Klein et al,12 or a higher incidence of complex cardiac surgery 
being undertaken at this specific centre. The decision by the authors to not specifically 
correct for regional variation was made in order to retain generalisation, enabling the scoring 
system to be used at centres outside those who participated in the initial cohort. 
Consequently, if a centre has policies or surgeons that mean transfusions are more likely 
(compared with the average in the audit) the score will underestimate risk, as evidenced by 
the results of the validation cohort. Whilst ACTA-PORT will still be useful to stratify the risk 
of transfusion in any presenting for surgery, the system will need to be recalibrated if centres 
outside of the control cohort wish to use it to predict absolute risk. We plan to design a 
simple App/online calculator to calculate the ACTA-PORT score when planning surgery or 
discussing risk with patients. 
Finally, the system makes use of the EuroSCORE10 as an overall marker of patient 
mortality.  This may limit the applicability of the scoring system beyond health systems that 
routinely collect this information, particularly centres in China29 and Australia.30 
Furthermore, risk prediction models are subject to constant revision,31 potentially further 
limiting the applicability of derived models that make use of them.   
In summary, using a large, multicenter cohort of patients collected from multiple 
cardiac centres, our group has derived a robust, simple and accurate system for predicting the 
risk of transfusion for patients undergoing cardiac surgery.  ACTA-PORT is the most 
accurate system of its kind to date, and may be used as part of a selection process for 
participation in a perioperative PBM program reducing the clinical and economic burden of 
transfusion.  Future research in this area will ideally include independent validation against a 
further external cohort, comparing ACTA-PORT with other bleeding/transfusion risk scores, 
as well as trialling incorporation of our score into a PBM program to enable stratification of 
transfusion risk and targeting interventions to mitigate this.  
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FIGURE LEGENDS 
 
Figure 1: The distribution of risk scores in our population; shows that the distribution follows 
a relatively normal curve and superimposed is a line showing the increasing risk of 
transfusion associated with higher scores. 
 
Figure 2: Observed vs. predicted transfusion rates in the derivation dataset, demonstrates the 
close correlation between predicted and observed rates of transfusion using our score across 
the range of scores in our derivation dataset. 
 
TABLES 
 
 All 
n=20,036 
Not transfused 
n=11,041 
Transfused 
n=8,638 
p-value 
Age; years 67.1 (11.9) 65.2 (12.0) 69.7 (11.3) <0.001 
Sex; men  14,303 
(71.4%) 
 9,093 (79.8%)  5210 (60.3%) <0.001 
Pre-operative Hb; g/L 
Missing data 
 132 (17) 
3237 (16.2%) 
 138 (15) 
2077 (18.2%) 
 125 (17) 
1160 (13.4%) 
<0.001 
Body surface area; m2  1.9 (0.2)  2.0 (0.2)  1.9 (0.2) <0.001 
Body mass index; kg/m2  28.4 (5.1)  29.0 (5.0)  27.6 (5.0) <0.001 
EuroSCORE 
 
Missing data 
 4.3 (2.1-8.7 
(0.4-98.4)) 
393 (2%) 
 3.2 (1.7-6.6 (0.4-
98.4)) 
238 (2.1%) 
 6.0 (3.1-11.7 (0.4-97.9)) 
 
155 (1.8%) 
 
Creatinine; µmol/L 
 
Missing data 
 88 (71-106 
(9-1547)) 
2172 (10.8%) 
 88 (71-97 (9-1547)) 
 
1254 (11%) 
 88 (71-106 (9-1450)) 
 
918 (10.6%) 
<0.001 
Diabetes 
 
Missing data 
 3916 (22.0%) 
 
2267 (11.3%) 
 2114 (20.7%) 
 
1208 (10.6%) 
 1802 (23.8%) 
 
1059 (12.3%) 
<0.001 
Hypertension 
 
Missing data 
 13,325 
(67.8%) 
384 (1.9%) 
 7,511 (67.2%) 
 
224 (2.0%) 
 5814 (68.6%) 
 
160 (1.9%) 
0.04 
Operation type       
 
CABG or valve* 14,575 (73%) 8,778 (77%) 5,797 (67%) 
 
Double procedure 2,858 (14%) 1,008 (9%) 1,850 (21%) 
 
Other 
 
Missing data 
2,594 (13%) 
 
9 (<0.1%) 
1608 (14%) 
 
7 (0.1%) 
986 (11%) 
 
2 (<0.1%) 
<0.001 
 
Table 1: Baseline characteristics. Values are mean (SD), number (proportion or median (IQR (range)). 
* Indicates isolated CABG or single valve surgery. 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
Centre All  
n=20,036 
Not transfused 
n=11,401 
Transfused 
n=8,638 
Transfusion rate  
A 2559 (13%) 1268 (11%) 1291 (15%) 50% 
B 732 (3%) 425 (4%) 307 (4%) 42% 
C 2058 (10%) 1410 (12%) 648 (8%) 31% 
D 2371 (12%) 1233 (11%) 1138 (13%) 48% 
E 5371 (27%) 3283 (29%) 2088 (24%) 39% 
F 500 (3%) 292 (3%) 208 (2%) 42% 
G 960 (5%) 423 (4%) 537 (6%) 56% 
H 1986 (10%) 1029 (9%) 957 (11%) 49% 
I 1099 (6%) 618 (5%) 481 (6%) 44% 
J 2400 (12%) 1420 (12.5%) 980 (11%) 41% 
 
Table 2: Anonymised centres. The difference in transfusion rates between centres was statistically significant (p 
< 0.001). 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
Table 3: Multivariable Risk Score outlining corresponding odds ratios, log odds ratios and how ACTA-PORT 
score was constructed, showing the number of score-points that were attributed to each group.   
 
 
 
Characteristic Category 
Odds ratio 
(95%) 
p-value 
Log odds ratio 
(SE) 
Points 
Age; years <70 Ref.      +0 
  70+ 1.11 (1.01, 1.21) 0.02 0.10 (0.04) +1 
Sex Male Ref.      +0 
  Female 1.27 (1.15, 1.40) <0.001 0.24 (0.05) +1 
Haemoglobin <110 6.36 (5.38, 7.52)  1.85 (0.09) +9 
g/L 110- 4.60 (3.93, 5.38)  1.53 (0.08) +8 
  120- 3.19 (2.79, 3.65)  1.16 (0.07) +6 
  130- 1.93 (1.70, 2.20)  0.66 (0.07) +3 
  140- 1.55 (1.37, 1.77)  0.44 (0.07) +2 
  150+ Ref.   <0.001   +0 
Body surface area <1.7 3.62 (2.97, 4.42)  1.29 (0.10) +6 
m2 1.7- 2.21 (1.85, 2.64)  0.79 (0.09) +4 
  1.9- 1.56 (1.31, 1.85)  0.44 (0.09) +2 
  2.1- 1.24 (1.04, 1.49)  0.22 (0.09) +1 
  2.3+ Ref.   <0.001   +0 
EuroSCORE <1 Ref.      +0 
  1- 1.36 (1.10, 1.70)  0.31 (0.11) +2 
  2- 1.73 (1.39, 2.15)  0.55 (0.11) +3 
  3- 2.16 (1.75, 2.68)  0.77 (0.11) +4 
  9+ 2.76 (2.20, 3.46) <0.001 1.01 (0.12) +5 
Creatinine  <88 Ref.      +0 
µmol/L 88- 1.33 (1.23, 1.44)  0.29 (0.04) +1 
  177- 1.93 (1.54, 2.42) <0.001 0.66 (0.12) +3 
Type of Operation CABG/Valve 1.38 (1.22, 1.55)  0.32 (0.06) +2 
  Combination 2.84 (2.46, 3.29)  1.05 (0.07) +5 
  Other Ref.   <0.001   +0 
Intercept   NA     -3.00 (0.15)   
  
 
 
Integer 
risk score 
Predicted risk of 
transfusion 
Integer 
risk score 
Predicted risk of 
transfusion 
0 0.0470 15 0.500 
1 0.0570 16 0.550 
2 0.0690 17 0.599 
3 0.0830 18 0.646 
4 0.1000 19 0.690 
5 0.1190 20 0.731 
6 0.1420 21 0.769 
7 0.1680 22 0.802 
8 0.1980 23 0.832 
9 0.2310 24 0.858 
10 0.2690 25 0.881 
11 0.3100 26 0.900 
12 0.3540 27 0.917 
13 0.4010 28 0.931 
14 0.4500 29 0.943 
15 0.5000 30 0.953 
 
Table 4: Integer risk score totals and associated predicted risk of transfusion. It demonstrates that low scores 
attract a very low risk of transfusion (i.e. a score of 1 gives a risk of transfusion as less than 5%) whereas a 
patient with a score of 30 would have more than a 95% risk of requiring a transfusion. 
 
 
 
 
 
 
 
